Ajai Chari

Ajai Chari, MD

  • ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology

Specialties:

Oncology, Hematology-Oncology

Dr Chari is an Associate Professor of Medicine, the Director of Clinical Research in the Multiple Myeloma Program, and the Associate Director of Clinical Research, Mt Sinai Cancer Clinical Trials Office. Clinical Interests: Plasma cell disorders, including multiple myeloma, AL amyloidosis, POEMS syndrome, plasmacytoma, and monoclonal gammopathies of uncertain significance (MGUS). Dr Chari has published extensively on these topics and has been invited to speak regionally, nationally, and also internationally. Research Interests: Dr Chari’s research interests include the development of novel chemotherapy regimens, including phase 1 and 2 studies. He is principal investigator (PI) of several investigator-initiated trials as well as the national and international PI of several industry sponsored studies. As the Director of Clinical Research in the Multiple Myeloma Program, he oversees a program renowned nationally not only for high volume patient accruals but also rigorous quality assurance. The program has played a pivotal role in the approval of each of the 5 most recent drugs to be approved by the FDA for the treatment of multiple myeloma.

Certifications

Hematology

Clinical Focus

  • AL Amyloidosis
  • Amyloidosis
  • Bone Marrow Transplantation
  • Bone Marrow Transplantation, Autologous
  • Clinical Trials
  • Hematologic Malignancies
  • Multiple Myeloma
  • Plasma Cell Neoplasms
  • Waldenström's Macroglobulinemia

Education

MD, UCLA School of Medicine

Residency, Internal Medicine, Columbia University Medical Center

Fellowship, Hematology & Onc., University of California - San Francisco